RK Ventures Group is the famous VC, which was founded in 1999. The main department of described VC is located in the New York. The company was established in North America in United States.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2010. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this RK Ventures Group works on 4 percentage points less the average amount of lead investments. The top activity for fund was in 2017.
We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the various public portfolio startups of the fund, we may underline Xenex, Respicardia, Redpoint Bio For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the RK Ventures Group, startups are often financed by BioAdvance, Pfizer Venture Investments, Lilly Ventures. The meaningful sponsors for the fund in investment in the same round are Pfizer Venture Investments, Lilly Ventures, BioAdvance. In the next rounds fund is usually obtained by Safeguard Scientifics, Pfizer Venture Investments, Lilly Ventures.
Funds with similar focus
Fund Name | Location |
CDH Solutions | Maryland, New Jersey, United States |
FastVentures | Budapest, Hungary |
Golden Valley Capital | England, London, United Kingdom |
Healthware Ventures | - |
Island Capital | New York, New York, United States |
Katalyst Venture Partners | Pennsylvania, Philadelphia, United States |
Leadpath Nigeria | Lagos, Lagos, Nigeria |
Telesystem Ltd. | Canada, Montréal, Quebec |
Unionen | - |
Welfare Tech invests | Denmark, South Carolina, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
KrazyBee | $8M | 16 Oct 2017 | Karnataka | ||
Respicardia | $21M | 17 Oct 2008 | Minnesota, United States | ||
Avid Radiopharmaceuticals | $26M | 09 May 2007 | Philadelphia, Pennsylvania, United States | ||
Avid Radiopharmaceuticals | $8M | 05 Jan 2006 | Philadelphia, Pennsylvania, United States | ||
Redpoint Bio | $10M | 13 Nov 2003 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
KrazyBee | $8M | 16 Oct 2017 | Karnataka | ||
Respicardia | $21M | 17 Oct 2008 | Minnesota, United States | ||
Avid Radiopharmaceuticals | $26M | 09 May 2007 | Philadelphia, Pennsylvania, United States | ||
Avid Radiopharmaceuticals | $8M | 05 Jan 2006 | Philadelphia, Pennsylvania, United States | ||
Redpoint Bio | $10M | 13 Nov 2003 | New Jersey, United States |